Up 222% in a year, why this ASX energy share is forecast to more than double your money again

A leading broker forecasts more outsized gains to come from this rocketing ASX energy share. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX energy share Elixir Energy Ltd (ASX: EXR) is charging higher today.

Again.

Elixir shares closed trading yesterday for 8.5 cents. In early afternoon trade on Tuesday, shares are changing hands for 8.7 cents apiece, up 2.4%.

For some context, the S&P/ASX Small Ordinaries Index (ASX: XSO) is up 0.1% at this same time.

Today's outperformance is par for the course for this junior ASX energy share.

Indeed, one year ago, on 24 March 2024, you could have picked up shares at an intraday low of 2.7 cents each.

Meaning you'd be sitting on eye-popping gains of 222.2% today. Or enough to turn an $8,000 investment into $25,778.

In one year.

And according to the investment team at Euroz Hartleys, Elixir Energy shares are well-positioned to more than double in value again.

Here's why.

Excited couple celebrating success while looking at smartphone.

Image source: Getty Images

ASX energy share drills into excellent prospect

Last Monday, 16 March, Elixir reported the final drilling results from its Lorelle-3H appraisal well, located in Queensland's Taroom Trough.

The ASX energy share closed up 7.1% on the day, with Elixir Energy CEO Stuart Nicholls noting, "The Lorelle-3 appraisal campaign has delivered an exceptional result for the company."

And Euroz Hartleys analyst Declan Bonnick agrees.

According to Bonnick:

EXR announced excellent results from the Lorelle-3 horizontal well (ATP 2056: 50% EXR, 50% STO) in the Taroom Trough, onshore Queensland. The well achieved >1km targeted length and intersected average porosity of 11.2%, with peaks up to 18%, materially exceeding our expectations and approaching conventional reservoir quality. The well has now been cased and suspended ahead of a planned frac/flow test program in Q2CY26.

And Elixir could be sitting on a gusher, judging by the outcome achieved to date by Shell PLC (NYSE: SHEL) on a nearby tenement.

Bonnick noted:

The Lorelle-3 results represent a key de-risking milestone in demonstrating the commerciality of EXR's Taroom Trough acreage. The upcoming 30-day multi-stage frac and flow test (targeting >5 MMscf/d) through Q2CY26 will be a critical step in confirming commercial deliverability.

The program mirrors the approach taken by neighbouring Supermajor Shell, which is progressing development directly on trend and is understood to have achieved commercial flow rates from the same reservoir.

What's the price target for Elixir shares?

Connecting the dots, Euroz Hartleys maintained its speculative buy rating for the junior ASX energy share.

Following last week's drill results, the broker increased its price target for Elixir Energy to 19 cents a share. That represents further upside potential of more than 118% from current levels.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Young boy with glasses in a suit sits at a chair and reads a newspaper.
Broker Notes

Sell Judo shares and 2 other ASX small caps: experts

ASX small-cap shares outperformed the broader market in FY26, but experts are calling time on these 3 stocks. Here's why.

Read more »

A young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Broker Notes

Buy, hold, sell: SKS Technologies, Yancoal, Wesfarmers shares

Let's check out some new ratings on ASX shares today.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Wisetech Global, CBA shares

Experts explain their ratings on 3 ASX 200 shares. 

Read more »

A female athlete in green spandex leaps from one cliff edge to another.
Broker Notes

Up 149% in a year, why this surging ASX 300 tech stock is still a good buy today

One expert weighs in.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Broker Notes

Up 75%, are Pro Medicus shares still a good buy now?

A leading analyst provides his forecast for Pro Medicus shares.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

5 things to watch on the ASX 200 on Monday

It looks likely to be a good start to the week for Aussie investors.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Focused man entrepreneur with glasses working, looking at laptop screen thinking about something intently while sitting in the office.
Broker Notes

Buy, hold, sell: BHP, CBA, and Rio Tinto shares

Morgans has been running the rule over these giants.

Read more »